Direct Ethanol Biomarker Testing: PETH - Insights
Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' new direct biomarker test for alcohol consumption. PETH is a blood test with a window of detection of about two to four weeks — compared with five days for urine-based screening for...
Sarcoma Informative Cases - Insights
Case #1 Case #2 Case #3 Case #4 Case #5 Sarcomas are malignant tumors that arise in the bone and soft tissue. With numerous subtypes of sarcoma that can
Focused lung panel informs the use of targeted cancer therapies - Insights
Ying-Chun Lo, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated lung panel can better guide clinical decision-making, particularly about targeted lung cancer therapies.
Customer Service Module - Insights
Customer Service Module Overview Exceptional customer service is essential for gaining new clients and maintaining customer loyalty. It is a key
Resources for patients - Insights
Discover helpful patient resources, including how to request an appointment at Mayo Clinic, test result information, information about diseases and conditions, Symptom Checker, and healthy lifestyle information.
Mayo Clinic Pathology System Upgrade Resource Page - Insights
To ensure we continue to provide the highest level of value-based reference laboratory services, Mayo Medical Laboratories will be implementing a new pathology laboratory information system on Friday, Sept. 8, 2017. View the list of...
In April 2021, Mayo Clinic Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Discontinuation of Herpes Simplex Virus (HSV) IgM Testing - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the over utilization of IgM serologic testing for herpes simplex virus and the recommendation by multiple agencies, including the CDC and the Infectious Diseases Society of...
Mayo Clinic Laboratories works closely with group purchasing organizations (GPOs) and purchasing groups (PGs) to provide clients access to our esoteric tests and services, delivering solutions that drive efficiency.
connective_tissue_disease_cascade.pdf
01/2024© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Connective Tissue Disease Cascade ≥20 U <20 U CTDC / Connective Tissue Diseases Cascade, Serum Cyclic citrullinated peptide antibodies,...
High-resolution targeted stimulant and phencyclidine (PCP) screen - Insights
In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the high-resolution targeted stimulant and PCP screening test from Mayo Clinic Laboratories, which offers sensitivity and specificity for use in the monitoring and management of...
Optic Neuritis in the Era of Biomarkers - Insights
Antibodies to aquaporin-4 and myelin oligodendrocyte glycoprotein (MOG) are recently described biomarkers seen in a subset of atypical optic neuritis which have revolutionized our understanding of the condition. In this “Hot Topic,” my...
@2021 Mayo Foundation for Medical Education and Research Framework for Quality Updated: 12/13/2024 Mayo Clinic Laboratories measure quality not simply by accreditation and licensure, but also by how efficiently esoteric laboratory...
Predictors to Direct Neural Antibody Testing in Autoimmune Encephalitis/Epilepsy - Insights
In this “Hot Topic,” Divyanshu Dubey, M.B.B.S., associate professor of laboratory medicine and pathology and neurology at Mayo Clinic, discusses various clinical and paraclinical features of autoimmune encephalitis, autoimmune seizures, and...
Pathways Case Studies - Insights
The Pathways program provides anatomic and clinical pathology cases that include a history, potential answers, rationale, and relevant references directly from Mayo Clinic fellows, physicians, scientists, and allied health staff.
A Snapshot of Mayo Clinic's Medical Laboratory Science Program - Insights
Ciara Dollar, a student in the Mayo Clinic Medical Laboratory Science program, provides a quick snapshot of what life in the program is like.
Learn more about how Mayo Clinic Laboratories’ genetic gastroenterology tests can provide diagnostic clarity across a range of inherited GI disorders.
Melanoma panel provides more tumor information - Insights
In this test specific episode of the "Answers From the Lab" podcast, Ruifeng (Ray) Guo, M.D., Ph.D., explains how Mayo Clinic Laboratories' comprehensive melanoma panel better informs prognosis and treatment.
Comprehensive panel boosts GIST diagnosis sensitivity - Insights
Rondell Graham, M.B.B.S., describes Mayo Clinic Laboratories' new assay for gastrointestinal stromal tumors, or GIST. The panel covers multiple mutations, to better inform diagnosis and treatment options.
MCL DrMcKeon PAVAL letter MC2775682
MCL DrMcKeon PAVAL letter Dear Colleague partnering Clinic Laboratories autoimmune neurology testing effort offer
MCL Familial Mutation Testing Required Patient Information MC1235202
MCL Familial Mutation Testing Required Patient Information Complete print Familial Variant Testing Required Patient Information Reset Form Instructions accurate interpretation reporting genetic results
MCL Molecular Genetics Congenital Inherited Diseases Patient Information MC123597
MCL Molecular Genetics Congenital Inherited Diseases Patient Information Complete print Reset Form Molecular Genetics Congenital Inherited Diseases Patient Information Instructions accurate interpretation reporting genetic
Multiomics: A new model for identifying biomarkers to predict severe COVID-19 outcomes - Insights
In a groundbreaking study, Mayo Clinic investigators have developed a multiomic molecular method to predict clinical COVID-19 (SARS-CoV-2) outcomes better than traditional cytokines. Using a machine-learning-based prediction model, the team...
Offering more than 150 oncology-specific tests in nine subspecialty areas, Mayo Clinic Laboratories’ cancer tests are developed by an experienced team of board-certified geneticists, genetic counselors, and physicians.
Serving more than 60 countries, Mayo Clinic Laboratories is creating a new standard for global diagnostic testing, offering international clients a vast test menu, access to Mayo Clinic experts, superior customer service, and more.
Demystifying the Tick with Bobbi Pritt, M.D. - Insights
The "Mpls-St Paul" magazine article highlights Bobbi Pritt, M.D., Director of the Clinical Parasitology Lab and Co-Director of Vector-Borne Diseases Lab Services in Mayo Clinic’s Department of Lab Medicine and Pathology, and her research on...
A Sysmex Game of Telephone - Insights
Rachel Olk, a student in the Mayo Clinic Medical Laboratory Science class of 2018, talks about her experience with the Sysmex Hematology Analyzer during a game of "Telephone" in the laboratory.
Mayo Clinic Laboratories’ fungal diagnostics test menu includes molecular and serological assays to aid in diagnosing a wide variety of fungal diseases, including those caused by Coccidioides possadasi/immitis, Histoplasma, Blastomyces, and...
Autoimmune neurology evolution - Insights
Patients with autoimmune neurologic conditions deserve the best chance at an accurate diagnosis. These answers can make a real difference in a patient’s treatment and quality of life.
Learn why liquid biopsy testing is a viable alternative to tissue-based biopsy testing for certain patients with cancer.
Molecular Detection for Tuberculosis Drug Resistance [Test in Focus] - Insights
Nancy Wengenack, Ph.D. gives an overview of this test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing compares to other testing approaches, and what clinical action can be...
celiac_disease_routine_treatment_monitoring_algorithm.pdf
12/2024© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Celiac Disease Routine Treatment Monitoring Algorithm# Patient with diagnosis of celiac disease Implementation of gluten-free diet (GFD) Perform...
laboratory_testing_for_infectious_causes_of_diarrhea.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. MCR 04/2025 Laboratory Testing for Infectious Causes of Diarrhea1 Community-acquired diarrhea, <7 days duration WITHOUT warning signs or risk factors for...
MCL Whole Genome Sequencing Ordering Checklist MC1235301
MCL Genome Sequencing Ordering Checklist Complete print Genome Sequencing Ordering Checklist Reset Form Instructions Select box test requested
The Ignorance of Laboratory Medicine - Insights
Justin Kreuter, M.D., reflects on the "ignorance" of laboratory medicine among clinical colleagues.
Mayo Clinic researchers identify new disease subtype linked to recurrent blood clots - Insights
Mayo Clinic researchers identify a new subtype of MGTS, linked to recurrent blood clots, with significant diagnostic challenges and treatment implications.
Hereditary peripheral neuropathy - Insights
Learn how our test menu can assist in identifying genetic causes across the spectrum of hereditary peripheral neuropathies.
Membranoproliferative glomerulonephritis (MPGN) is a pattern of glomerular injury. Based on the etiology of MPGN, Drs. Sethi and Fervenza proposed a new histologic classification of MPGN into Ig/IC-mediated MPGN and complement-mediated...
Allan Dietz, Ph.D., Director of the Human Cellular Therapy Laboratory (HCTL) at Mayo Clinic, was recently profiled in Mayo Clinic Magazine, highlighting his background and work in the HCTL.
Testing Archives - Page 16 of 25 - Insights
Skip to Content MayoACCESS MayoLINK...
Staffing to Workload in Phlebotomy Areas: Indirect Effort - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses staffing to workload in phlebotomy areas with a focus on indirect effort, which includes tasks performed that don’t involve the patient or a patient’s sample.
Active Learning: Connecting Teachers and Learners - Insights
Cindy Gosse, Education Specialist in the Department of Laboratory Medicine and Pathology at Mayo Clinic, discusses how to use active learning to better connect teachers and learners.
Staffing to Workload in Phlebotomy Areas: Minimum Staffing Levels - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses staffing to workload in phlebotomy areas with a focus on minimum-staffing levels, which can override the calculated staffing needs by adding staff to meet potential demands.
Using CSI-Type Technology to Unravel the Source of Bacteria - Insights
Mayo Clinic laboratory workers have a new tool to perform high tech genetic sleuthing for the source of stubborn, sometimes life-threatening bacteria.
Endocrinology Testing - Mayo Clinic Laboratories
Standardization of procedures and protocols is essential for the reliable interpretation of dynamic endocrine testing results. Our test menu includes more than 70 common and esoteric analytes and is constantly growing.
A Test in Focus Archives - Page 10 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
Malabsorption - Mayo Clinic Laboratories
Stool testing is a critical component of diagnosing EPI and Mayo Clinic Laboratories offers multiple tests to help clinicians in their work-up of these patients.
Peroxisomal biogenesis and metabolism - Insights
Learn more about how Mayo Clinic Laboratories’ testing for peroxisomal biogenesis and metabolism disorders can assist in the identification of these sometimes fatal conditions.
Thiopurine Management Testing for IBD - Mayo Clinic Laboratories
Thiopurine management is important because it can detect individuals with low thiopurinemethyltransferase (TPMT) activity who are at risk for excessive myelosuppression or severe hematopoietic toxicity when taking thiopurine drugs.
Membranous nephropathy - Insights
Membranous nephropathy (MN) is one of the leading causes of nephrotic syndrome in adults. Our menu of clinically validated assays assists with diagnosis, monitors disease progression, and guides clinical outcomes.